Agfa HealthCare - Second Quarter 2013

Agfa HealthCareMainly due to adverse currency effects, Agfa HealthCare's revenue decreased by 2.0 percent to 294 million Euro. Excluding currency effects, revenue remained almost stable. In the Imaging segment, the digital radiography business (consisting of Computed Radiography, Direct Radiography and the hardcopy business) performed strongly, mainly due to the success of the DR product range. The traditional X-ray product range's revenue dropped considerably compared to the second quarter of 2012. In last year's second quarter, the traditional business was marked by a strong recovery following slow sales in earlier months.

Excluding currency effects, the IT segment's revenue remained stable. The Enterprise IT business continued its upward trend, whereas the Imaging IT business was rather soft compared to the very strong second quarter in 2012. On a year-to-date basis, Imaging IT continued to grow according to plan. Due to the well-filled order book, sales for Imaging IT are expected to pick up towards the end of the year.

Agfa HealthCare's gross profit margin amounted to 34.7 percent of revenue, versus 36.3 percent in the second quarter of 2012. Margins were influenced by mix effects and by investments to further improve service efficiency and to prepare the introduction of new solutions. Recurring EBITDA reached 28.7 million Euro (or 9.8 percent of revenue). Recurring EBIT amounted to 18.9 million Euro (or 6.4 percent of revenue).

In May, Agfa HealthCare established a new subsidiary in the Kingdom of Saudi Arabia. By setting up the Agfa HealthCare Saudi Arabia Company Ltd., the business group will be able to enhance its support to its customers in this important region.

In the field of digital radiography, Agfa HealthCare launched its NX MUSICA2 Platinum and NX MUSICA2 Neonatal image processing solutions for use with direct radiography (DR) technology. The solutions render excellent bone and soft tissue detail simultaneously in a single exposure. NX MUSICA2 Platinum is suitable for both adults and pediatric patients. NX MUSICA2 Neonatal is designed to meet the demanding requirements of neonatal imaging.

The installed base for Agfa HealthCare's innovative DR solutions continued to grow in the second quarter. In the UK, for instance, Agfa HealthCare successfully implemented its DX-D 600 DR system at Wrightington, Wigan and Leigh NHS Foundation Trust. In the USA, the business group installed six DX-D 100 mobile DR systems at the Department of Defense's Medical Education & Training Campus for use in the basic biomedical equipment technician training curriculum.

In Imaging IT, Agfa HealthCare released ICIS View 3.0, the medical images and results viewer for the comprehensive ICIS (Imaging Clinical Information System) enterprise imaging solution. The system allo ws clinicians, specialists and other stakeholders to access all patient imaging data from any Picture Archiving and Communication System (PACS), using a single viewer. The ICIS solution creates a true imaging record for every patient, containing all possible images of the patient, regardless of the hospital department and de facility that created them.

In May, Agfa HealthCare announced the signing of a new contract that makes the business group's full suite of imaging IT solutions available to the customers of Novation, a leading healthcare supply contracting company in the USA. Included in the contract are Agfa HealthCare's IMPAX departmental and ICIS enterprise imaging solutions.

Among the new customers for Agfa HealthCare's ORBIS Enterprise IT solution were the following hospitals in Northern Germany: the St. Marienhospital Ankum-Bersenbrück GmbH, the CKT Marienhospital Steinfurt GmbH and the STENUM Fachklinik für Orthopädie.

About Agfa
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were 1,180 million euro.

Most Popular Now

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...